Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adventa BhdXKLS:7191 30 Debt-to-Equity is 0.20 as of Mar. 2026, which is 11% above its 10-year median of 0.18. GuruFocus rates XKLS:7191 with a GF Score™ of 30/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 703 Medical Devices & Instruments companies, Adventa Bhd ranks better than 53.34% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Adventa Bhd's Debt-to-Equity or its related term are showing as below:
XKLS:7191'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.18 Max: 0.7
Current: 0.2
During the past 13 years, the highest Debt-to-Equity Ratio of Adventa Bhd was 0.70. The lowest was 0.01. And the median was 0.18.
XKLS:7191's Debt-to-Equity is ranked better than 53.34% of 703
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs XKLS:7191: 0.20
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Adventa Bhd Debt-to-Equity Related Terms
Adventa Bhd Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Adventa Bhd's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7191 vs ISRG, BDX, MDLN: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, Adventa Bhd's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adventa Bhd Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Adventa Bhd's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adventa Bhd (XKLS:7191) has a Debt-to-Equity of 0.20 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Adventa Bhd and its competitors. This is 11% above median its historical median of 0.18. Over the past decade, Adventa Bhd's Debt-to-Equity has ranged from 0.01 to 0.70. According to the industry distribution chart, Adventa Bhd ranks #328 out of 703 companies in the Medical Devices & Instruments industry, placing it in the top 46.7%.
Is Adventa Bhd's Debt-to-Equity too high?
Adventa Bhd's current Debt-to-Equity of 0.20 is 11% above median its 10-year median of 0.18. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.70. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. Adventa Bhd's value of 0.20 is 13% below this industry median. Based on the distribution chart, Adventa Bhd ranks #328 out of 703 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Adventa Bhd has a GF Score™ of 30/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #328 out of 703 companies for Debt-to-Equity. This puts Adventa Bhd in the upper half of its industry. The industry median Debt-to-Equity is 0.23. Adventa Bhd's value of 0.20 is 13% below this benchmark. Historically, Adventa Bhd's own Debt-to-Equity has ranged from 0.01 to 0.70 over the past decade. While the company's 10-year median is 0.18 vs. the industry median of 0.23, Adventa Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adventa Bhd's current Debt-to-Equity of 0.20 is 13% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Adventa Bhd and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adventa Bhd's current Debt-to-Equity is 0.20, which is 11% above median its own 10-year median of 0.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 47.9% below its estimated fair value. The current Debt-to-Equity is 0.20, which is 11% above median its 10-year median of 0.18 and 13% below the Medical Devices & Instruments industry median of 0.23. Adventa Bhd's overall GF Score™ is 30/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current Debt-to-Equity is 0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adventa Bhd (XKLS:7191) Overvalued in 2026?
Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued.
The current stock price of RM0.13 is trading 47.9% below its estimated GF Value™ of RM0.24.
GuruFocus considers Adventa Bhd to be Possible Value Trap.
Key valuation signals for XKLS:7191:
Debt-to-Equity: 0.20 (11% above median its 10-year median of 0.18)
GF Value™: RM0.24 vs. price of RM0.13 (47.9% below fair value)
Industry Position: 13% below the Medical Devices & Instruments median (#328 of 703)
No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
30GF Score
Get the complete analysis for XKLS:7191
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7191 has been successfully added to your 
